Back to search results

A Study of TAK-360 in Adults With Narcolepsy Type 1 (Narcolepsy With Cataplexy)

Abroad (travel likely)RecruitingPHASE2

Conditions

Narcolepsy Type 1

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Takeda Site 12, Redwood City, California, United States

  • Takeda Site 14, Miami, Florida, United States

  • Takeda Site 13, Cincinnati, Ohio, United States

  • Takeda Site 2, Macquarie Park, New South Wales, Australia

  • Takeda Site 4, Beijing, Beijing Municipality, China

  • Takeda Site 3, Guangzhou, Guangdong, China

  • Takeda Site 5, Zhengzhou, Henan, China

  • Takeda Site 6, Herault, Montpelier, France

  • Takeda Site 7, Paris, France

  • Takeda Site 8, Bologna, Emilia-Romagna, Italy

  • Takeda Site 9, Verona, Veneto, Italy

  • Takeda Site 17, Fukuoka, Fukuoka, Japan

  • Takeda Site 1, Kumamoto, Kumamoto, Japan

  • Takeda Site 18, Isahaya-shi, Nagasaki, Japan

  • Takeda Site 15, Yodogawa-ku, Osaka-shi, Osaka, Japan

  • Takeda Site 16, Shinjuku-ku, Tokyo, Japan

  • Takeda Site 11, Barcelona, Spain

  • Takeda Site 10, Madrid, Spain

Study leads

  • Study Director

    Takeda

View source on ClinicalTrials.gov(opens in a new tab)